MedEffect e-Notice from Health Canada | Alertec Contraindications in Pregnancy

On June 20, 2019 Health Canada released a MedEffect Notice advising of an increased risk of spontaneous abortion and major congenital anomalies, including cardiac congenital anomalies in babies born to mothers who use modafinil (brand name ALERTEC) during pregnancy. The NHPPA questions the systematic removal of natural health products from the market when the risks associated with pharmaceuticals far outweighs any risk associated with the use of natural remedies. If you are an alternative medicine practitioner, what would you consider supporting women with when facing “excessive tiredness symptomatic of narcolepsy, obstructive sleep apnea and shift-work disorder”.